By Manas Mishra (Reuters) -Shares of U.S. drugmakers fell before the bell on Monday after reports that the Food and Drug ...

Shares in Moderna, Vaxcyte, Novavax and BioNTech all fell Monday after Peter Marks, head of the FDA office that reviews ...

FORESTER FIRED: Gov. Stitt elaborates on ouster as fire crew, community outrage grows President Donald Trump has made U.S.

Access the Rangers beat like never before Join Post Sports+ for exciting member-only features, including real-time texting ...

Ousting of Oklahoma Forestry Services Director Goeller draws criticism from AG Drummond, acknowledging the heroism of ...

Ouster's growth potential, competitive edge, and strong financial outlook make it a top buy, with a $27 target. Learn why ...

Yes, there were some big hits like 'Reacher.' But pricey underperformers like 'Lord of the Rings' and 'Citadel' along with ...

The ice cream giant accused its parent company of removing its CEO because of his support for the brand’s activism.

Oppenheimer initiated coverage on shares of Ouster (NYSE:OUST – Free Report) in a research note released on Thursday, MarketBeat reports. The brokerage issued an outperform rating and a $16.00 price ...

On Monday, Ouster stock earned a positive adjustment to its Relative Strength (RS) Rating, from 80 to 95. IBD's proprietary RS Rating identifies technical performance by using a 1 (worst ...

NatWest Group Plc has settled a yearslong dispute with Nigel Farage, a prominent Brexit campaigner and Member of Parliament, ...

Ouster is a high-growth LiDAR technology company with a strong balance sheet, but breakeven is still several years away. The merger with Velodyne has expanded Ouster's customer base, improved ...